Wordt geladen...
Summary of the 2019 BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling
The Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Myeloma Intergroup has organized an annual workshop focused on minimal residual disease (MRD) testing and immune profiling (IP) in multiple myeloma since 2016. In 2019, the workshop took place as an American Society of Hematology (ASH...
Bewaard in:
| Gepubliceerd in: | Biol Blood Marrow Transplant |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7529908/ https://ncbi.nlm.nih.gov/pubmed/32589921 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2020.06.011 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|